Chief Executive Officer
Wed, Nov 15, 2023
Nov 15
exercised or converted securities in DAWN
3,562 shares @ $0.00
Decreased holdings by -11.10%
Net across this filing: +0.70% (+5,205 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology